Article

First CRISPR clinical trial gets green light from US panel

2016-06-22

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 03583e2d-3cd5-5e5a-8911-e8f2e3859829
DOI: 10.1038/nature.2016.20137

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

First CRISPR clinical trial gets green light from US panelDOI 10.1038/nature.2016.20137Read

An Update on the Application of CRISPR Technology in Clinical PracticeSemantic proximity Read

CRISPR therapeutics push into human testingSemantic proximity Read

CRISPR-based therapeutics: current challenges and future applicationsSemantic proximity Read

Progress and challenges towards CRISPR/Cas clinical translationSemantic proximity Read

Erratic journey of CRISPR/Cas9 in oncology from bench-work to successful-clinical therapySemantic proximity Read

Les débuts de CRISPR en thérapie géniqueSemantic proximity Read

Applications of CRISPR as a potential therapeuticSemantic proximity Read

Clinical trials and promising preclinical applications of CRISPR/Cas gene editingSemantic proximity Read

Towards affordable CRISPR genomic therapies: a task force convened by the Innovative Genomics InstituteSemantic proximity Read

Measurement and clinical interpretation of CRISPR off-targetsSemantic proximity Read

The first human trial of CRISPR-based cell therapy clears safety concerns as new treatment for late-stage lung cancerSemantic proximity Read

First Trial of CRISPR-Edited T cells in Lung CancerSemantic proximity Read